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Abstract
Background
Conventional diagnostic methods for human ascariasis are based on the detection of Asca-
ris lumbricoides eggs in stool samples. However, studies of ascariasis in pigs have shown
that the prevalence and the number of eggs detected in the stool do not correlate well with
exposure of the herd to the parasite. On the other hand, an ELISA test measuring antibodies
to Ascaris suum haemoglobin (AsHb) has been shown to be useful for estimating transmis-
sion intensity on pig farms. In this study, we further characterized the AsHb antigen and
screened samples from a population-based study conducted in an area that is endemic for
Ascaris lumbricoides in Indonesia to assess changes in AsHb antibody rates and levels in
humans following mass drug administration (MDA).
Methodology/Principal findings
We developed and evaluated an ELISA to detect human IgG4 antibodies to AsHb. We
tested 1066 plasma samples collected at different times from 599 subjects who lived in a vil-
lage in rural Indonesia that was highly endemic for ascariasis. The community received 6
rounds of MDA for lymphatic filariasis with albendazole plus diethylcarbamazine between
2002 and 2007. While the AsHb antibody assay was not sensitive for detecting all individu-
als with Ascaris eggs in their stools, the percentage of seropositive individuals decreased
rapidly following MDA. Reductions in antibody rates reflected decreased mean egg output
per person both at the community level and in different age groups. Two years after the last
round of MDA the community egg output and antibody prevalence rate were reduced by
81.6% and 78.9% respectively compared to baseline levels.
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Conclusion/Significance
IgG4 antibody levels to AsHb appear to reflect recent exposure to Ascaris. The antibody
prevalence rate may be a useful indicator for Ascaris transmission intensity in communities
that can be used to assess the impact of control measures on the force of transmission.
Author Summary
Ascariasis is a neglected tropical disease caused by the intestinal nematode Ascaris lumbri-
coides that affects hundreds of millions of people in the developing world. Current meth-
ods for diagnosis of this infection are based on detecting eggs in the stool that are excreted
by adult Ascaris worms. However, these methods have limited sensitivity for recent infec-
tions, and they do not detect infections with immature parasite stages that do not always
result in the establishment of adult worms in the human intestine. We have previously
shown that an assay for antibodies to Ascaris hemoglobin in pig serum is useful for assess-
ing transmission of Ascaris infections on pig farms. In this study, we developed and evalu-
ated a similar antibody assay that is based on the detection of human IgG4 antibodies to
Ascaris haemoglobin (AsHb). Community antibody rates decreased rapidly following
mass drug administration of the anthelmintic drug albendazole, and this decrease reflected
reduced Ascaris egg excretion at the community level. This antibody test may be a useful
tool for assessing the impact of control measures on the transmission of new Ascaris infec-
tions in endemic populations.
Introduction
An estimated 1.45 billion people worldwide are infected with three soil transmitted helminths
(STH) Ascaris lumbricoides, Trichuris trichiura, or hookworms [1]. Among the STH, infections
with A. lumbricoides are most common and its public health impact is estimated to be approxi-
mately 1.31 million daily adjusted life years (DALYs) [1]. Current STH control programs are
focused on morbidity control through community based deworming of school-aged children
by annual or semiannual administration of a single dose of anthelmintics such as albendazole
or mebendazole [2]. In addition, the large elimination programs for lymphatic filariasis and
onchocerciasis provide anthelminthics to entire at risk populations that are also effective
against A. lumbricoides [3, 4].
The intensity of A. lumbricoides infection is routinely measured by the number of eggs per
gram (EPG) in stool by the Kato-Katz fecal thick-smear technique [5]. This method is useful
for quickly assessing infection prevalence rates for evaluating the efficacy of control programs.
However, the sensitivity of the Kato Katz smear is reduced in areas with low infection rates and
intensities [6]. Furthermore, it is a time-consuming and cumbersome technique, and eggs in
stool do not necessarily correlate well with the intensity of exposure to new infections with
migrating stages of the parasite that are major contributors to morbidity caused by the parasite
[7]. Therefore, it would be useful to have a practical method to measure the intensity of expo-
sure to new infections at the population level. Research on the value of antibody assays for STH
infections has been limited to date apart from interesting work on strongyloidiasis [8–10]. One
reason for this is that people did not consider antibody testing to be a priority for common
infections that can be diagnosed by microscopy. Also, it is commonly believed that antibody
tests will not be able to distinguish between current and past infections. Only a handful of
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studies have evaluated antibody tests for ascariasis. Most of these studies used crude somatic
antigen preparations or excretion/secretion (E/S) products derived from larvae or adult para-
sites cultivated in vitro. These antigens are difficult to procure and generally lack specificity
[11–15].
Recently, Vlaminck et al., [16] evaluated a serological test for the detection of ascariasis in
fattening pigs based on the detection of IgG antibodies to A. suum haemoglobin (AsHb) in
serum samples by ELISA. The AsHb antigen is highly produced and secreted by both the adult
and larval stages [17, 18]. Validation studies with samples from naturally and experimentally
infected pigs showed that the antibody assay was superior to detection of eggs in feces for
detecting exposure to the infection. A subsequent study showed that antibody reactivity to
AsHb correlated with liver pathology caused by migrating A. suum larvae, and high antibody
rates in pig herds were associated with low growth rates (reduced farm productivity) [19].
There are many parallels between ascariasis in pigs and in humans that is caused by the
closely related species A. suum and A. lumbricoides, respectively. Therefore, the purpose of the
present study was to investigate the potential value of anti-AsHb antibody testing for commu-
nity diagnosis of human ascariasis.
Materials and Methods
Parasite cDNA and AsHb
Adult A. suum parasites were collected with permission from the intestines of infected pigs that
were being processed as part of the normal work at a local abattoir in Ghent, Belgium. The
fresh worms were snap frozen in liquid nitrogen for subsequent storage at -80°C. Tissue
homogenization and mRNA extraction and cDNA construction were essentially performed as
described in Rosa et al [20]. The AsHb antigen was purified according to the protocol described
by Vlaminck et al [17]. The protein sequence of AsHb was obtained from the Entrez Protein
Database of the National Center for Biotechnology Information (NCBI), USA (http://www.
ncbi.nlm.nih.gov/protein) with the following accession number: AAA29374.1 (A. suum). Pro-
tein orthologs of AsHb in other nematode species were identified by a BLASTP search on
WormBase ParaSite (http://parasite.wormbase.org/) against the available protein sequence
databases for the following species (A. suum (PRJEB80881); A. lumbricoides (PRJEB4950),
Toxocara canis (PRJEB533), Strongyloides stercoralis (PRJEB528), Necator americanus
(PRJNA72135), Ancylostoma ceylanicum (PRJNA72583), Enterobius vermicularis (PRJEB503),
Brugia malayi (PRJNA10729),Wuchereria bancrofti (PRJEB536), Loa loa (PRJNA60051), and
Trichuris trichiura (PRJEB535)). The presence of signal peptides was detected using SignalP
4.1 software [21].
Cloning of AsHb
The AsHb product was amplified from parasite cDNA by reverse transcriptase- polymerase
chain reaction (RT-PCR) using the primer pair AsHbFw (CACCATGCGCTCATTGCTATT
ATTATCG) and AsHbRv (TCAGTGTTGCTCTTCCTTATGC) and according to the amplifi-
cation protocol described in Vlaminck et al [17]. The amplified PCR product was cloned into
pET100/D-TOPO vector and transformed into One Shot TOP10 competent cells according to
the manufacturers protocol (Invitrogen, Carlsbad, CA, USA). Positive colonies were analyzed
using PCR and the PCR products were sequenced. One positive transformant was selected and
the plasmid was purified using the PureLink HQMini Plasmid Purification Kit (Invitrogen).
The plasmid DNA was used as template for the amplification of AsHb using the same primers
as previously mentioned. The PCR product was sequenced to verify that the insert was in-
frame for expression.
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Prokaryotic expression and purification of rAsHb
The AsHb-containing vector construct was transformed into BL21 Star (DE3) One Shot cells
and cells were grown in Luria Broth (Miller) (Sigma, St. Louis, MO, USA) containing 50μg/ml
carbenicillin (Sigma). Overnight cultures of the transformed bacteria were diluted 1:100 in LB
+ carbenicillin and grown at 37°C with shaking to an optical density of approximately 0.5–0.8
at 600nm. Protein expression was induced by addition of isopropylthiogalactoside to the cul-
ture medium to a final concentration of 1 mM. After 4h of incubation at 37°C under vigorous
agitation (250 rpm), E. coli cells were pelleted by centrifugation and suspended in 1:25 of the
initial culture volume of ice-cold RIPA lysis and extraction buffer (G Biosciences, St. Louis,
MO, USA), incubated on shaking device at room temperature (RT) for 30 min and then centri-
fuged for 10 min at 4.500 g. The pellet was suspended again in RIPA lysis and extraction buffer
and the previous incubation and centrifugation step was repeated twice more. The final pellet
was dissolved in binding buffer (50mM Phosphate buffer, 0.5M NaCl, 10mM imidazole and
7M guanidine hydrochloride, pH 8.0). The recombinant protein was then bound to a HIS-Se-
lect Cobalt Affinity Gel column (Sigma) followed by a column wash with 5x column volumes
of binding buffer and eluted from the column using elution buffer (50mM sodium phosphate
buffer, 500mMNaCl, 7M guanidine hydrochloride, 250mM imidazole, pH 8.0). The eluate was
dialyzed overnight against PBS in a Slide-A-Lyzer Dialysis Cassette, 7K MWCO (Thermo
Fisher Scientific, Pittsburg, PA, USA) and subsequently concentrated on a Millipore centrifugal
filter unit (Millipore, Billerica, MA, USA). Protein dye binding and BCA protein assay
(Thermo Fisher Scientific) were used to determine the protein concentration.
Human plasma samples and assessment of STH infections
Plasma samples were collected from individuals living in Mainang village on Alor Island (Prov-
ince of East Nusa Tenggara, Timor, Indonesia) as part of a study of the impact of annual MDA
with diethylcarbamazine (DEC) combined with albendazole (ALB) on Brugia timori and STH
infections [22]. Only the most prevalent geohelminths, A. lumbricoides, hookworm and T. tri-
chiura were analyzed in this study, since other species such asHymenolepis spp. and S. stercora-
lis were only found in a few cases [23]. Baseline prevalence for A. lumbricoides, T. trichiura and
hookworm in the whole community were 32.2%, 25.3%, and 9.4% respectively [23]. The STH
infection rates and egg densities were assessed with single Kato Katz smears in 2002 (prior to
any mass drug administration, MDA) and in 2009, two years after the sixth and last annual
round of MDA. For these years, community egg output was determined as the sum of EPG of
all people divided by the total number of tested individuals. Prevalence rates for STH in stool
in 2004 and 2007 were assessed by the formalin ether enrichment method. Additionally, at
baseline, 17.6% of the individuals had B. timorimf in their blood [23].
Plasma samples used in the present study were collected in 2002 prior to the first round of
MDA, after 2 rounds of MDA (2004), just prior to the sixth and final round of MDA (2007),
and 2 years after the last round of MDA (2009).
Other plasma samples used in this study were from people living in the East Sepik region of
Papua New Guinea. Hookworm infection rates in this study area were over 90% and no A. lum-
bricoides infections were detected by Kato Katz examination of one stool sample per subject in
any of these study communities. Non-endemic control plasma samples were from American
subjects in St. Louis, MO, USA.
SDS-PAGE andWestern blot
Protein samples were denatured and reduced in LDS 4x sample buffer (Thermo Fisher scien-
tific) and separated by SDS-PAGE using Bolt 4–12% Bis-Tris Plus minigels (Thermo Fisher
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Scientific) under reducing conditions and either stained with SimplyBlue Safestain Coomassie
stain (Invitrogen) for the visualization of the proteins or transferred onto nitrocellulose mem-
branes for immunostaining as previously described [24]. After blotting, nitrocellulose mem-
branes were blocked at room temperature for 1hr with 5% non-fat dry milk (BioRad, Hercules,
CA, USA) in PBS, and then incubated with human plasma diluted 1:50 in PBS + Tween20
(0.05%) (PBST) and incubated at room temperature (RT) for 2h. After incubation with a sec-
ondary antibody (mouse anti human IgG4 pFc-HRP (Southern biotech, Birmingham, AL,
USA), blots were washed with PBST and antibody binding was detected using CN/DAB Sub-
strate kit (Thermo Fisher Scientific).
Deglycosylation of AsHb and analysis of the carbohydrate groups
AsHb was deglycosylated with PNGase F according to the manufacturer’s protocol (New
England Biolabs, Ipswich, MA, USA). Briefly, 10μg of AsHb was mixed with 10x denature
buffer and H2O to make a 20μl total reaction volume that was denatured at 100°C for 10 min.
This was followed by addition of 10X Glycobuffer 2, 10% NP-40 and 1μl of PNGase F (500,000
U/ml) and H2O to obtain a total reaction volume of 40μl that was incubated at 37°C for 2h.
Finally, the deglycosylated product (dAsHb) was passed over a detergent binding spin column
(Thermo Fisher Scientific) to remove the detergent that was added during the deglycosylation
reaction. RNAseB treated with PNGase F was included as deglycosylation control.
For mass spectrometric (MS) analysis, N-glycans released with PNGase-F from 5μg of
AsHb were labeled with 2-aminobenzoic acid (anthranilic acid, AA), as described [25]. MAL-
DI-TOF-MS was performed in the negative ion reflector mode on an Ultraflextreme instru-
ment (Bruker Daltonics, Germany) using DHB as matrix, as described [26]. Putative glycan
structures were assigned on the basis monosaccharide compositions deduced from the
observedm/z values.
Phosphorylcholine (PC) specific monoclonal antibodies (TEPC-15) (Sigma) were used to
detect the presence of PC in AsHb and dAsHb by Western blot and ELISA. Anti-PC antibodies
were detected with HRP conjugated anti-mouse IgA (Sigma) and nitro-blue tetrazolium/
5-bromo-4-chloro-30-indolyphosphate substrate (Sigma). PC linked to bovine serum albumin
was used as a positive control.
Detection of IgG4 antibodies to AsHb by ELISA
Previous serological experiments performed by Santra et al., 2001 [13] and Chatterjee et al.,
1996 [14] showed that human IgG4 responses to a fractionated adult E/S antigen of Ascaris
were superior in reactivity and also showed less cross reactivity than IgG1, IgG2 and IgG3 sub-
class antibodies in sera from patients infected with hookworm, Trichuris and Strongyloides.
This, in combination with the results from earlier experiments performed in the lab, led to the
decision to use the IgG4 subclass antibody as detecting antibody in the immunological assays
described in this study.
Antigen (AsHb, rAsHb or dAsHb) was coated at a concentration of 1μg/ml overnight at 4°C
on Nunc Maxisorp flat-bottomed 96 well plates (Sigma) in 100μl coating buffer (0.05M carbon-
ate/bicarbonate buffer pH9.6). Following incubation, plates were washed 3 times with wash
buffer (PBST: 0.05% PBS-tween 20, pH 7.2). Nonspecific binding sites were blocked by dis-
pensing 100 μl of PBS with 5% FCS in each well and incubating the plates for 2h at 4°C. For the
inhibition ELISA, an extra blocking step was included where PC-groups on the AsHb were
blocked by incubating the coated wells with TEPC-15 antibodies diluted 1:500 in blocking
buffer for 2 h. After blocking, plates were washed as before and plasma or antibody samples
were added to the wells. Plasma samples were diluted 1:50 in PBST and 100 μl of each sample
Reduced Ascaris Antibody Rates after Mass Drug Administration
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was tested in duplicate. Plates were incubated for 2h at RT and afterwards washed as previously
described. Secondary antibodies (mouse anti-human IgG4 pFc’-HRP (Southern biotech)) were
diluted 1:2,000 in blocking buffer and plates incubated for 1h at RT. Finally, plates were washed
and 100μl of the o-phenylenediamine dihydrochloride substrate solution (Thermo Fisher Sci-
entific) was added to each well. The substrate reaction was stopped after 10 minutes by adding
50μl of stop solution (4M H2SO4) and optical densities at 490nm were recorded. The cutoff for
positivity was calculated as the arithmetic mean OD + 3 times the standard deviation obtained
with 10 non-endemic plasma samples from St. Louis, Missouri, USA.
Statistical analysis
All statistical analyses were performed using GraphPad Prism v6.0 software (La Jolla, CA,
USA). Infection prevalence rates at baseline and subsequent time points were compared with
the McNemar test. Infection intensities (EPG) and ELISA OD values for paired samples were
compared using the Wilcoxon signed rank test. Correlations between EPG and AsHb ELISA
OD values were assessed with the Spearman’s rank correlation test. The statistical significance
of differences in ELISA OD values obtained with different antigens (AsHb, dAsHb and rAsHb)
was assessed with the Wilcoxon signed rank test.
Ethical clearance
The Ethics Committee of the University of Indonesia, Jakarta approved the sample collection in the
Alor Island study as previously described [22]. The Institutional Review Boards at CaseWestern
Reserve University and the Papua New GuineaMedical Research Advisory Committee approved
the protocol for sample collection, and all study participants provided informed consent. The Insti-
tutional Review Board atWashington University School of Medicine waived the need for an addi-
tional review for our use of de-identified human serum samples for this in vitro study.
Accession numbers
Genbank: AAA29374.1. Wormbase: GS_08371, ALUE_0001899801, ALUE_0001446901,
NECAME_07759 ANCCEY_14143, TCNE_0001552801.
Results
Detection of AsHb by human antibodies onWestern blot
In order to evaluate whether antibodies of infected humans were detecting AsHb, a select num-
ber of endemic and non-endemic control plasma samples were first used to evaluate the recog-
nition of AsHb by Western blot and ELISA. Six of 8 endemic plasma samples with proven A.
lumbricoides infection (>25 EPG) and 4 of 5 individuals with negative stool examinations had
IgG4 antibodies that recognized AsHb (Fig 1). In contrast, none of the non-endemic control
plasma samples detected AsHb onWestern blot or showed strong reactivity on ELISA. A cut-
off for ELISA positivity was determined, based on the OD values of the 10 non-endemic plasma
samples that were tested. The cut-off was set at an OD of 0.38.
Specificity of the AsHb IgG4Western blot was also assessed with plasma samples collected
in an area in Papua New Guinea where hookworm infection is nearly universal but ascariasis
and trichuriasis are absent. Since 7 of the 12 samples tested had IgG4 antibodies to AsHb (S1
Fig), it appears that some people with hookworm infections develop IgG4 antibodies to
AsHb to some degree. A BLASTP search using the AsHb protein sequence obtained from Gen-
Bank (AAA29374.1) on Wormbase Parasite revealed two sequences in A. lumbricoides
(ALUE_0001899801 and ALUE_0001446901) with>99% amino acid sequence identity. Both
Reduced Ascaris Antibody Rates after Mass Drug Administration
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Fig 1. Native AsHb is recognized by human IgG4 antibodies in plasma samples from individuals living
in an A. lumbricoides endemic area. (A) The recognition of AsHb by human IgG4 antibodies onWestern
blot; lane 1 = conjugate control, lane 2–4 = Non-endemic controls, lane 5–10 = endemic plasma samples
without visible parasite eggs in the stool, lane 11–17 = endemic plasma samples from individuals with A.
lumbricoides eggs in the stool. (B) ELISA OD values for the same endemic plasma samples and 10 non-
endemic plasma samples. The number next to each point on the dot plot corresponds with the lane numbers
for theWestern blot. The OD values of the 10 non-endemic individuals were used to calculate the cutoff
(0.380) indicated on this plot by a dotted line.
doi:10.1371/journal.pntd.0004532.g001
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sequences form a perfect alignment with AsHb (S2 Fig). Both N. americanus and A. ceylani-
cum have orthologs to AsHb (NECAME_07759 and ANCCEY_14143 respectively) with
sequences that were shorter than the AsHb (88 AA and 97 AA respectively) with sequence
identity in the overlapping region of 51.1% and 46.4% and E values of 1e-25 and 2.7e-24 respec-
tively. The ortholog in the canine ascarid Toxocara canis (TCNE_0001552801) has 69.6%
amino acid sequence identity and also showed to contain a signal peptide. No AsHb orhtolog
(E-value< 1e-05) was present in Trichuris spp. (S1 Table).
Changes in STH infection rates and antibody prevalence rates to AsHb
following mass drug administration in Mainang village, Indonesia
This part of the study used ELISA to detect human IgG4 antibodies to AsHb in plasma samples
collected before and after MDA. All parasitological and serological data obtained in this study
is provided as supplementary information (S2 Table). STH prevalence results before and after
MDA are shown in Table 1. Although the prevalence of A. lumbricoides infection decreased
significantly from 38.2% to 15.7% after 2 years of MDA (a 58.9% reduction; P< 0.01), the
prevalence rate rebounded to 24.4% in 2007 (a 36.1% reduction from baseline; P< 0.01) and to
29.5% in 2009 (a 22.8% reduction from baseline, P = 0.09). In contrast, the average egg output
in the community was 81.6% lower in 2009 than in 2002 (128.2 vs. 697.9, P< 0.01). Hook-
worm and T. trichiura infections were also reduced by MDA (both 1.8% in 2007), however in
2009 hookworm infection rates returned to pre-MDA levels (10.4%) and T. trichiura rates also
rebounded (2.3%) [22]. The average community egg outputs for hookworm and whipworm
did not change significantly between 2002 and 2009 (5.4 to 6.9 and 3.1 to 1.4 respectively).
A total of 1,066 plasma samples were tested by AsHb ELISA, and these included samples
collected prior to any MDA and at intervals following multiple rounds of MDA (Table 1).
Employing the earlier determined OD cut-off for the ELISA, 67.6% of the individuals were
Table 1. Prevalence of A. lumbricoides, hookworm and T. trichiura infections based on stool examination and serological examination for A. lum-
bricoides infections during and after mass drug administration with DEC + albendazole in a subset of the treated population that was studied from
2002 to 2009 on Alor Island, Indonesia.
Year of the study
2002 2004 2007 2009 % reduction 02 vs 09
No of stool samples examined (qualitatively/quantitatively) 280/280 280/0 279/0 173/173
A. lumbricoides % positive (n) 38.2 (107) 15.7 (44) 24.4 (68) 29.5 (51) 22.9
Ascaris community egg output1 697.9 / / 128.2 81.6*
Hookworm % positive (n) 8.9 (25) 3.6 (10) 1.8 (5) 10.4 (18) -16.5
Hookworm community egg output1 5.4 / / 6.9 -27.8
T. trichiura % positive (n) 6.8 (19) 0.4 (1) 1.8 (5) 2.3 (4) 65.9
T. trichiura community egg output1 3.1 / / 1.4 53.0
No of plasma samples 476 399 100 91
% seropositive samples (n) 67.6 (322) 22.6 (90) 23.0 (23) 14.3 (13) 78.9*
No of samples with both EPG and serology data for Ascaris 240 220 68 64
% that are sero + and egg + (n) 27.5 (66) 4.5 (10) 13.2 (9) 4.7 (3)
% that are sero + and egg–(n) 37.9 (91) 15.0 (33) 14.7 (10) 6.3 (4)
% that are sero–and egg + (n) 10.0 (24) 10.5 (23) 14.7 (10) 26.6 (17)
% that are sero–and egg–(n) 24.6 (59) 70.0 (154) 57.4 (39) 62.5 (40)
(* P < 0.01)
1 Community egg output = sum of EPG / total number of tested persons.
doi:10.1371/journal.pntd.0004532.t001
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seropositive at baseline (Table 1, Fig 2 and S3 Fig). After two years of MDA, seroprevalence
was significantly reduced to 22.6% in 2004 (P< 0.001) and this was unchanged in 2007
Fig 2. Human IgG4 response against native AsHb is reduced by MDA intervention. Plasma samples
were analyzed at baseline (2002), after two years of MDA (2004), at the end of the trial, prior to the final MDA
(2007), and 2 years after the end of the trial (2009). Antibody reactivity decreased significantly after MDA. The
lines connect plasma samples from the same individuals collected in different years of the study. The red
dotted line represents the OD cutoff of 0.380 (* P < 0.05, ** P < 0.01, *** P < 0.001).
doi:10.1371/journal.pntd.0004532.g002
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(23.0%). The seropositivity rate in 2009 had further decreased in comparison to 2007 (14.3%,
P< 0.05).
In both 2002 and 2009 there was no significant relationship between AsHb ELISA OD val-
ues and stool egg counts for any of the STH (S4 Fig). In 2002, 66 of 90 egg positive (73.3%) and
91 of 150 (60.7%) egg negative individuals were seropositive by anti-AsHb ELISA. However, in
2009 only 3 of 20 egg positive (15%) and 4 of 44 (9.1%) egg negative individuals were
seropositive.
There was a drastic and significant reduction in both egg prevalence and seroprevalence
between 2002 and 2004 in all age groups. Egg prevalence increased again in 2007 and 2009
across all age groups until it almost reached pre-treatment levels whereas seroprevalence did
not change after 2004. Similarly, the mean number of eggs excreted by the people in a specific
age category was also significantly reduced from 2002 to 2009 over all age categories (Fig 3).
Recognition of AsHb, dAsHb and rAsHb by human IgG4 antibodies
In order to work towards better standardization of the test, we also evaluated whether infected
human sera would recognize recombinant AsHb. The AsHb gene was cloned from adult worm
cDNA and expressed in E. coli. The protein profile of the purified rAsHb was identical to that
of AsHb after Coomassie staining (S5 Fig). Antibodies in a pooled plasma sample from
humans with Ascaris infection did not bind to rAsHb by Western blot (Fig 4). To test whether
the presence of N-glycan groups on AsHb was important for immune recognition, the native
AsHb was deglycosylated with PNGase F to remove any N-linked glycans. A shift in molecular
weight was seen in the PNGase F deglycosylated AsHb (dAsHb), indicating the removal of N-
linked glycans. This molecular weight shift was not visible after treatment of the rAsHb with
PNGase F indicating the absence of PNGase F digestible carbohydrate groups (S5 Fig). Anti-
bodies in pooled plasma from A. lumbricoides infected individuals did not bind to dAsHb by
Western blot.
In order to quantify this effect, IgG4 reactivity of 10 plasma samples from Indonesian indi-
viduals from 2002 to AsHb, denatured AsHb, dAsHb and rAsHb were evaluated by ELISA (Fig
4). After normalization of the data using the AsHb OD 490 as reference, a significant relative
increase in antibody binding (59%, P< 0.05) was seen after denaturing the AsHb. The opposite
was true for dAsHb and for rAsHb that were less immunoreactive than the native antigen
(-42%, P< 0.05 and -88%, P< 0.01, respectively.
Identification of PNGase F released glycans of AsHb
In order to further characterize the glycans present on AsHb that were important for immune-
recognition of the antigen, the N-glycan structures were removed from the protein backbone
by PNGase F and analyzed by MALDI-TOF-MS. The glycan spectrum of the released N-gly-
cans of AsHb is shown in Fig 4. Major [M-H]- signals were observed atm/z 1176.9, 1380.0 and
1583.2, derived from glycans with the compositions F1N2H3, F1N3H3 and F1N4H3 (F, fucose;
N-acetylhexosamine, H, hexose) glycans, respectively, interpreted as α1,6-fucosylated triman-
nosyl N-glycan core structures substituted with 0–2 GlcNAc residues (indicated in Fig 4). An
additional major signal was observed at m/z 1545.1 (F1N3H3+165.1) indicative for the phos-
phorylcholine (PC) substituted variant of F1N3H3 which is in line with previous observations
for N-glycans of A. suum [27]. Further, minor signals at m/z 1748.3 (F1N4H3PC), 1786.3
(F1N5H3) and 1913.4 (F1N4H3PC2) were observed indicating that additional substitutions with
HexNAc residues and PC can occur. Incubation of both AsHb and dAsHb with mouse anti-PC
monoclonal antibodies (TEPC-15) proved the presence of PC in native AsHb and its absence
after deglycosylation with PNGase F (S6 Fig). The recognition of AsHb by human IgG4
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Fig 3. Changes in age-specific Ascaris infection rates, AsHb antibody rates, and average egg output per age group for different times before and
after MDA. Prevalence based on eggs in the stool (A) or serology (B) shows a notable reduction over all age categories between the year 2002 and 2004.
While the prevalence goes back up in all age categories based on the presence of eggs in the stool in subsequent years, the percentage seropositive
individuals remains low. (C) The average group egg output (sum of EPG divided by the number of people analyzed per group) is also reduced between 2002
and 2009 over all age categories. Too few subjects (less than 5) younger than 10 years of age were tested in 2007 and 2009 to produce meaningful data for
this age category.
doi:10.1371/journal.pntd.0004532.g003
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Fig 4. Characterization and importance of N-glycans for the recognition of AsHb by human IgG4 antibodies. (A) Recognition of AsHb, PNGase F
deglycosylated native AsHb (dAsHb), and recombinant AsHb produced in E. coli (rAsHb) onWestern blot by IgG4 of pooled A. lumbricoides infected human
plasma samples. (B) Comparison of ELISA results obtained with IgG4 antibodies from 10 humans with ascariasis vs. AsHb, denatured AsHb (den AsHb),
Reduced Ascaris Antibody Rates after Mass Drug Administration
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antibodies was not significantly reduced when AsHb was pre-incubated with anti-PC antibod-
ies before addition of positive human plasma samples (S6 Fig).
Discussion
The results of this study suggest that measurement of antibodies to AsHb may be a useful
approach for assessing exposure of human populations to A. lumbricoides infection. Egg excre-
tion per person and antibody rates decreased in parallel following MDA while the infection
prevalence rate in 2009 was not very different from the baseline rate. The implementation of
MDA probably reduced the number of Ascaris eggs that were excreted in the environment. As
a result, the ingestion of infective eggs and exposure to migrating stages of the parasite is likely
to have decreased in all age categories in the population. This may explain why the antibody
rate decreased further between 2007 and 2009 despite suspension of the MDA program after
2007. However, since we do not have quantitative coprological data for the years 2004 and
2007, we do not have precise information on the impact of MDA on infection intensities
between 2002 and 2007.
Despite the limited sequence similarity between the AsHb orthologs identified in both
hookworm species, our results confirm antigenic cross reactivity between hookworm and A.
lumbricoides [28]. Thus, reduced antibody reactivity to AsHb after MDAmay have been partly
due to the effects of MDA on hookworm prevalence or transmission. However, the significant
rebound in hookworm prevalence that occurred between 2007 and 2009 (from 1.8% to 10.4%)
was not associated with a rise in antibody rates to AsHb. This study did not investigate anti-
body responses to AsHb in people infected with T. trichiura. However, the absence of an AsHb
homologue in the Trichuris genome and the fact that antibodies in sera from pigs experimen-
tally infected with T. suis had little if any reactivity with AsHb [16] suggest that humans
infected with T. trichiura who have not been infected with Ascaris are not likely to have signifi-
cant antibody responses to AsHb.
We acknowledge that using the AsHb ELISA would be too insensitive to identify or diag-
nose active A. lumbricoides infection in an individual. However, it is important to notice that
the goal of our study was to evaluate the use of this serological test as diagnostic marker for
exposure on a community level and not for individual diagnosis of infection. Unlike for A.
suum infections in pigs, where experimentally infected pigs can serve as “true gold standard”,
there is no such standard available to assess the sensitivity of a serological tool for diagnosis of
STH infections in humans [6]. However, since this ELISA would be used to assess transmission
intensity on a community level, this is not a major obstacle.
Recombinant antigens are often preferred for serodiagnosis of parasitic infections. One rea-
son for this is that native antigens are sometimes difficult to obtain and purify. However, in the
case of AsHb, the antigen is relatively easy to purify from A. suum. In addition, antibodies
from infected individuals were only weakly reactive with recombinant AsHb produced in this
study or with AsHb after treatment with PNGase F. This finding suggests that IgG4 human
antibodies to AsHb are mostly directed against N linked glycan epitopes present on the native
antigen. Shared carbohydrate epitopes pose a challenge for developing specific serology tests
for helminth infections. Parasites with AsHb orthologs with low amino acid sequence identity
may contain the same or similar carbohydrate epitopes that could be responsible for antigenic
crossreactivity.
dAsHb and rAsHb. The average% change relative to AsHb is shown above the bars with * for differences with P values of < 0.01. (C) Anthranilic acid (AA)-
labeled glycans released by PNGase-F from AsHb identified by MALDI-TOF-MS. The major glycans detected were core-α1,6-fucosylated trimannosyl N-
glycans with GlcNAc residues that were partially substituted by phosphorylcholine (PC). Red triangle, fucose; blue square,N-acetylglucosamine; green
circle, mannose; white square,N-acetylhexosamine; *, unidentified non-glycan signal.
doi:10.1371/journal.pntd.0004532.g004
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Mass spectrometric analysis of the glycans released by PNGase F treatment of AsHb
detected PC-substituted GlcNAc moieties. Blocking the PC-group with TEPC-15 antibodies
did not result in a significant blocking of binding of human antibodies to AsHb by ELISA. This
result suggests that other glycans motifs may be important antigenic components of AsHb and
it is consistent with a previous study that reported that humans do not develop IgG4 subclass
antibodies to the PC epitope [29].
The simplicity, affordability and speed of the Kato Katz test has made it the most widely
used method for estimating STH infection rates and intensities in large scale control programs
[30]. This has important policy implications, because current WHO guidelines for STH pre-
ventive chemotherapy are based on infection prevalence rates as assessed by a single Kato-Katz
smear with little attention paid to intensity [31]. However, prevalence is not everything.
Because of the high degree of aggregation of STH infections, significant reductions in average
worm loads may result in small or unnoticeable changes in prevalence rates [32]. Also, infec-
tion intensities for ascariasis are often reported according to the broadWHO categories of light
(< 5,000 EPG), moderate (5,000–50,000 EPG) or heavy (>50,000 EPG). However, it is unclear
whether these categories are appropriate for use in all endemic regions, because of considerable
geographic variability in egg production per adult female Ascaris worm [33].
The use of diagnostic tools that are based on the detection of Ascaris eggs or DNA in the
stool has significant shortcomings when it comes to the accurate estimation of true prevalence
or intensity of the infection. For one thing, only a small fraction of the total number of parasite
larvae that migrate through the body ever develop into adult worms in the intestine. For
worms that reach the intestine, egg output per worm can vary widely because of different para-
site sex ratios, the age distribution of the adult worms, and host immunity [7]. Thus the
absence of A. lumbricoides eggs in the stool does not necessarily prove there has been no recent
infection or exposure with larval stages. Animal studies have shown that larval stages contrib-
ute significantly to morbidity caused by Ascaris infections [34, 35], and this should be consid-
ered as part of the health impact of ascariasis in humans as well.
Our results show that IgG4 antibody responses to AsHb do not correlate with A. lumbricoides
egg output. This is consistent with results from other studies that have compared anti-Ascaris
antibody responses to adult worm counts or EPG in stool [12, 36]. Furthermore, several studies
have shown that anti-Ascaris antibody responses are rather dependent on exposure and infection
intensity as opposed to being protective or predictive of future levels of infection [36–39].
A significant percentage of people in Alor Island who had Ascaris eggs in their stool lacked
IgG4 antibodies to AsHb, and this situation became more common later in the trial when com-
munity egg loads were reduced. It is interesting that a number people with more than 500 EPG
were seronegative in 2009. While there are several possible explanations for this, we favor the
idea that antibody responses to AsHb are stimulated much more by new infections when larvae
are migrating through tissues and than by the presence of low numbers of adult worms in the
intestinal lumen. When the infection pressure has been reduced to low levels, exposure to new
infections with migrating larvae may not be sufficient to induce or maintain IgG4 antibodies to
AsHb. Furthermore, experimental infections in pigs have already shown that the number of
adult worms in the gut seems almost inversely correlated with the number of eggs ingested [40,
41]. Hence, with lower infection intensities, the chance of larvae establishing in the gut and
developing into adult worms increases. It would be interesting to elucidate the effect of infec-
tion dose on anti-AsHb responses in pigs, and this might help to explain changes in antibody
rates in human populations when infection pressure declines following MDA.
Although AsHb serology is not sensitive for detecting active Ascaris infections in individu-
als, it appears to be a promising new tool for quantifying exposure to Ascaris infection at the
community level. That is to say, it may provide a useful measure of egg input and incoming
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infection in communities even though it is not sensitive for predicting the presence of eggs in
the stool in individuals. Serological surveys for antibodies to AsHb and other STH antigens
could be an attractive alternative to stool examination for integrated post-MDA surveillance
programs for lymphatic filariasis (LF) and STH, because post-MDA surveys for LF collect fin-
ger prick blood samples for use in point of care serology tests [3], and finger prick blood could
also be used for STH serology. AsHb serology could also be used as an alternative to Kato-Katz
test for mapping the distribution of STH infections, because it should be useful for identifying
areas with high transmission rates that have the highest need for intervention.
The crossreactivity with hookworm and possibly Strongyloides stercoralis and Toxocara spp.
limits the value of AsHb serology if one is interested in ascariasis alone. Work to develop a
more species-specific antibody assay is ongoing. However, hookworm and Ascaris crossreactiv-
ity may not be a major flaw for the practical use of AsHb serology, since the same drugs are
used to treat both of these infections. We believe that this study has provided a useful proof of
principle for the value of antibody serology as an epidemiological tool for assessing STH trans-
mission pressure in populations and for monitoring the impact of STH intervention on trans-
mission pressure. We have shown that AsHb antibody rates correlate well with egg output per
person in populations, and they are also likely to correlate well with recent egg input in individ-
uals. However, additional research is needed on this topic. First, it will be necessary to confirm
the findings from this study with samples from other areas with high rates of ascariasis. Second,
it would also be interesting to evaluate changes in serology over time in different subpopula-
tions or to use serology to try and pinpoint when children are first exposed to STH.
Supporting Information
S1 Table. Homologs of AsHb determined by NCBI BLAST search of the nr database and
detection of possible secretory signal peptide.
(XLSX)
S2 Table. Raw data file with all parasitological and serological data used in this study.
(XLSX)
S1 Fig. Some humans living in a hookworm endemic area develop IgG4 antibodies to
AsHb. Lane 1 = conjugate control, lane 2 = positive control pooled plasma from A. lumbri-
coides infected individuals, lane 3 = pooled non-endemic control plasma, lane 4–15: plasma
from individuals from a hookworm endemic area in Papua New Guinea.
(TIF)
S2 Fig. Alignment report showing protein alignment of AsHb (AAA29374.1 and
GS_08371) and two sequences (ALUE_0001446901 and ALUE_0001899801) identified in
A. lumbricoides (AA that differ from consensus are indicated in red).
(TIF)
S3 Fig. Human IgG4 response against native AsHb of a subset of 42 individuals that were
tested at each time-point in the study. Plasma samples were analyzed at baseline (2002), after
two years of MDA (2004), at the end of the trial, prior to the final MDA (2007), and 2 years
after the end of the trial (2009). The lines connect plasma samples from the same individuals
collected in different years of the study. The red dotted line represents the OD cutoff of 0.380
( P< 0.05,  P< 0.01,  P< 0.001).
(TIF)
S4 Fig. Correlation plots for IgG4 antibody levels against AsHb and EPG levels for A. lumbri-
coides (A), hookworm (B) and T. trichiura (C) at baseline (2002) and 2 years after 6 rounds of
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MDA (2009).
(TIF)
S5 Fig. Amplification of the AsHb gene product, purification and deglycosylation of AsHb
and rAsHb. (A) AsHb cDNA was amplified from total adult A. suum cDNA. (B) The AsHb
was cloned and expressed in E. coli and purified by affinity chromatography. The native
(AsHb) and recombinant AsHb (rAsHb) look identical on Coomassie stained SDS-PAGE gel.
(C) A Coomassie stained SDS-PAGE gel of the AsHb and rAsHb before and after deglycosyla-
tion with PNGase F.
(TIF)
S6 Fig. Presence of Phosphorylcholine (PC) on AsHb. (A) The recognition on Western blot
of AsHb, dAsHb and PC linked to bovine serum albumin (BSA-PC) by anti-PC monoclonal
antibodies (TEPC-15). (B) A Tukey box plot representing the values of 20 A. lumbricoides posi-
tive (EPG) plasma samples shows no significant (NS) difference in the intensity of detection of
AsHb and AsHb that was blocked with TEPC-15 antibodies (1:500 dilution) for 2 hours.
(TIF)
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